Active

XMED

Switched

BE0630634810

Rechtspersoon Private limited company 2 establishments

Jan Van Looylaan(Kok) 5, 8670 Koksijde Groothandel in farmaceutische en medische artikelen

Active for

11 year, 3 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 40,016

▼ 29% vs 2024

Profit

Caution

€ -7,870

▲ 92% vs 2024

Debts

High

€ 775,472

▼ 1% vs 2024

XMED from Koksijde, company number BE0630634810, closed financial year 2025 with a result of € -7,870 after tax. For that financial year XMED recorded a gross margin of € 40,016 and equity of € -638,978. Compared with financial year 2024, the result moved from € -103,436 to € -7,870. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.

What happened at XMED?

What happened at XMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 7,870. Source: NBB ↗
  • New establishment in Veurne. KBO
  • Nuphar Tech BV became a director. NBB
  • APOTHEEK DE STERRE BV became a director. NBB
  • New establishment in Koksijde. KBO
  • Start of the company according to the CBE. KBO

In short

From € 168,364 loss in 2021 to € 7,870 loss in 2025.

Paid € 15,438 in corporate taxes since 2021.

A new publication or filing at XMED? We notify you, reason included.

Follow XMED

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind XMED are Nuphar Tech BV and APOTHEEK DE STERRE BV. The same people are also behind Nascendi.

See the full network in the app

Directors

According to the 2025 annual accounts

Nuphar Tech BV

Director · represented by Baes Kris

Also active at: Nascendi

since 2024

APOTHEEK DE STERRE BV

Director · represented by Haghedooren Yves

since 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Jan Van Looylaan(Kok) 5

8670 Koksijde

2.390.794.731

Albert I laan 31

8630 Veurne

Active since 15 June 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0630.634.810
VAT number
BE 0630.634.810
Registered office
Jan Van Looylaan(Kok) 5, 8670 Koksijde
Names & denominations
XMED
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
16 May 2015
Peppol
Active · Active since 2 Jul 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Overige niet-gespecialiseerde detailhandel

Markt- en opinieonderzoek

Opslag

Groothandel in informatie- en communicatieapparatuur

Groothandel in elektronische en telecommunicatieapparatuur en delen daarvan

Detailhandel via postorderbedrijven of via internet

Frequently asked questions

What is the enterprise number of XMED?
The enterprise number of XMED is BE0630634810.
What is the address of XMED?
The registered office of XMED is located at Jan Van Looylaan(Kok) 5, 8670 Koksijde.
When was XMED founded?
XMED was founded on 16 May 2015.
What is the main activity of XMED?
The main activity of XMED is "Groothandel in farmaceutische en medische artikelen" (NACE code 46460).
Does XMED have a website?
No website is currently known for XMED.
How much profit did XMED make in 2025?
XMED recorded a loss after taxes of € 7,870 in financial year 2025.
What is the revenue of XMED?
As a small company, XMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 40,016.
Where can I find the annual accounts of XMED?
XMED files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of XMED?
According to the 2025 annual accounts, the directors of XMED are: Nuphar Tech BV, APOTHEEK DE STERRE BV.
Who owns XMED?
Behind XMED are Nuphar Tech BV and APOTHEEK DE STERRE BV. The same people are also behind Nascendi.